Why Geron Stock Is Falling After Hours
Geron Corp (NASDAQ: GERN) shares are trading lower in Wednesday's after-hours session after the company announced a
Palisade Bio Announces Closing of $2.5M Registered Direct Offering, Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Palisade Bio, Inc. (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has closed its previously
Geron Corporation Announces $175M Proposed Public Offering Of Common Stock
Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced that it intends to offer and sell $175 million of shares of its common stock in an underwritten public offering.
Palisade Bio Announces $2.5M Registered Direct Offering And Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Palisade Bio, Inc. (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has entered into definitive
GT Biopharma, Inc. Announces $6.5M Registered Direct Offering Priced At Premium To Market
GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ:GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural